The coronavirus outbreak is prompting investors to visit the healthcare sector, a trend that could benefit ETFs, including the SPDR S&P Biotech ETF (NYSEArca: XBI). XBI, one of the largest biotechnology ETFs by assets, uses an equal-weight methodology, meaning it tilts toward smaller companies,...